Similarly, tumour hypoxia and CAIX expression are critical drivers [71,72] of the aggressive biology in patients diagnosed with cervical cancer and are likely to influence the prognostic capacity of G-CSF [15]. The gene discussed is CA9; the disease is cervical carcinoma.